Analysis of x-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: axially arrayed TTR monomers constitute the protofilament

References

• Shirahama T, Cohen A S. High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol 1967; 33: 679–708
   PubMed Web of Science ®Google Scholar
• Sipe J. Amyloidosis. Annu Rev Biochem 1992; 61: 947–975
   PubMed Web of Science ®Google Scholar
• Serpell L C, Sunde M, Fraser P E, Luther P K, Morris E P, Sangren O, Lundgren E, Blake C CF. Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J Mol Biol 1995; 254: 113–118
   PubMed Web of Science ®Google Scholar
• Costa P P, Figueira A S, Bravo F R. Amyloid fibril protein related to prealubumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978; 75: 4499–4503
   PubMed Web of Science ®Google Scholar
• Thylen C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: Analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBOJ 1993; 12: 743–748
   PubMed Web of Science ®Google Scholar
• Blake C CF, Geisow J J, Oatley S, Rerat J. B, Rerat C. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 1978; 121: 339–356
   PubMed Web of Science ®Google Scholar
• Benson M D, Uemichi T. Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1996; 3: 44–56
   Web of Science ®Google Scholar
• Steinrauf L K, Hamilton J A, Braden B C, Murrell J R, Benson M D. X-ray crystal structure of the Ala-109 Thr variant of human transthyretin which produces euthy-roid hyperthyroxinemia. J Biol Chem 1993; 268: 2425–2430
   Web of Science ®Google Scholar
• Hamilton J A, Steinrauf L K, Liepnieks J, Benson M D, Holmgren G, Sandgren O, Steen L. Alteration in molecular structure which results in disease: The Met-30 variant of human plasma transthyretin. Biochim Biophys Acta 1992; 1139: 9–16
   PubMedGoogle Scholar
• Hamilton J A, Steinrauf L K, Braden B C, Liepnieks J, Benson M D, Holmgren G, Sandgren O, Steen L. The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30 + Met variant to 1.7–Å resolution. J Biol Chem 1993; 268: 2416–2424
   PubMed Web of Science ®Google Scholar
• Terry C J, Damas A M, Oliveira P, Saraiva M JM, Alves I L, Costa P P, Matias P M, Sasaki Y, Blake C CF. Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 1993; 12: 735–741
   PubMed Web of Science ®Google Scholar
• Hamilton J A, Steinrauf L K, Braden B C, Murrell J R, Benson M D. Structural changes in transthyretin produced by the Ile 84 Ser mutation which result in decreased affinity for retinol-binding protein. Amyloid: Int J Exp Clin Invest 1996; 3: 1–12
   Web of Science ®Google Scholar
• Damas A M, Ribeiro S., Lamzin V S, Palha J A, Saraiva M J. a) Structure of Val22Ile variant transthyretin - a cardiomyopathic mutant. Acta Cryst 1996; D52: 966–972
   Google Scholar
• Sebastiao P, Dauter Z, Saraiva M J, Damas A M. Crystallization and preliminary x-ray diffraction studies of Leu55Pro variant transthyretin. Acta Cyst 1996; D52: 566–568
   Google Scholar
• Damas A M, Sebastiao M P, Ribeiro S, Palha J, Saraiva M J. Structural alterations in Ile-122 and Pro-55 variant TTRs: Their importance in amyloid formation. Neuromuscular Disorders 1996b; 6: S7, (abstract)
   Google Scholar
• Lai Z, Colón W, Kelly J W. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 1996; 35: 6470–6482
   PubMed Web of Science ®Google Scholar
• Damas A, Sebastiilo M P, Dorningues F S, Costa P P, Saraiva M J. Structural studies on FAP fibrils: Removal of contaminants is essential for the interpretation of x-ray data. Amyloid: Int J Exp Clin Invest 1995; 2: 173–178
   Web of Science ®Google Scholar
• Blake C, Serpell L. Synchrotron x-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous P-sheet helix. Structure 1996; 4: 989–998
   PubMed Web of Science ®Google Scholar
• Skinner M, Shirahama T, Cohen A S, Deal C L. The association of amyloid P-component (AP) with the amyloid fibril: An updated method for amyloid fibril protein isolation. Prep Biochem 1983; 12: 461–476
   Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell M G. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Nutl Acad Sci USA 1990; 87: 2843–2845
   PubMed Web of Science ®Google Scholar
• Nguyen J T, Inouye H, Baldwin M A, Fletterick R J, Cohen F E, Prusiner S B, Kirschner D A. X-ray diffraction of scrapie prion rods and PrP peptides. J Mol Biol 1995; 252: 412–422
   PubMedGoogle Scholar
• Inouye H, Fraser P E, Kirschner D A. Structure of P-crystallite assemblies formed by Alzheimer P amyloid protein analogues: Analysis by x-ray diffraction. Biophys J 1993; 64: 502–519
   PubMed Web of Science ®Google Scholar
• Inouye H, Kirschner D A. X-ray diffraction analysis of scrapie prion: Intermediate and folded structures in a peptide containing two putative a-helices. J Mol Biol 1997; 268: 375–389
   PubMed Web of Science ®Google Scholar
• McRee D E. A visual protein crystallographic software system for XII/X View. J Molec Graphics 1992; 10: 44–46
   Google Scholar
• Jones T A, Zou J Y, Cowan S W, Kjeldgaard M. Improved methods for the building of protein models in electron density maps and the location of errors in these models. Acta Crystallogr 1991; A47: 110–119
   Google Scholar
• Fraser R DB, MacRae T P. An investigation of the structure of p-keratin. J Mol Biol 1962; 5: 457–466
   Google Scholar
• Elder M, Hitchcock P, Mason R, Shipley G G. A refinement analysis of the crystallography of the phospho-lipid 1,2-dilauroyl-DL-phosphatidylethanolamine and some remarks on lipid-lipid and lipid-protein interactions. Proc Roy Soc Lond A 1977; 354: 157–170
   Web of Science ®Google Scholar
• Colon W, Kelly J W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation. in vitro. Biochemistry 1992; 31: 8654–8660
   PubMed Web of Science ®Google Scholar
• Gustavsson A, Engstrom U, Westermark P. Transthyretin (TTR)-derived amyloid fibrils: Immunoelectron microscopy of fibrils formed in vivo, in vitro from synthetic peptides and normal transthyretin. Amyloid: Int J Exp Clin Invest 1997; 4: 1–12
   Web of Science ®Google Scholar
• Cornwell G G, Sletten K, Johanssen B, Westermark P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealubumin. Biochem Biophys Res Commun 1988; 154: 648–653
   PubMed Web of Science ®Google Scholar
• Hermansen L F, Bergman T, Jornvall H, Husby G, Ranlev I, Sletten K. Purification and characterization of amyloid-related transthyretin associated with familial arnyloidotic cardiomyopathy. Eur J Biochem 1995; 227: 772–779
   PubMedGoogle Scholar
• Klug A, Crick F HC, Wyckoff H W. Diffraction by helical structures. Acta Crystallogr 1958; 11: 199–213
   Web of Science ®Google Scholar
• Marsh R E, Corey R B, Pauling L. The structure of Tussah silk fibroin. Acta Ctystallogr 1955; 8: 710–715
   Google Scholar
• Kelly J W. Amyloid fibril formation and protein misassembly: A structural quest for insights into amyloid and prion diseases. Structure 1997; 5: 595–600
   PubMed Web of Science ®Google Scholar
• Alexander L E. X-Ray Diffraction Methods in Polymer Science. Robert E Krieger Publishing Co, Huntington, NY 1979; 137–197
   Google Scholar